IQVIA Korea posted revenue of 196.11 billion won ($144.77 million) in 2025, up 190 percent from 67.62 billion won in 2015, ...

Humedix will invest about 3.3 billion won ($2.4 million) in research and development through 2029 after being selected for a government program supporting companies with global growth potential.The ae ...

Chronic obstructive pulmonary disease (COPD) patients who struggle to inhale strongly enough to use dry-powder inhalers (DPIs ...

Korea's national health insurance system spent 394.1 billion won ($289 million) on care for type 2 diabetes patients with ...

Large health insurance arrears among self-employed subscribers more than doubled over four years, even as total overdue ...

Drug utilization review (DUR) checks for obesity drug Mounjaro reached 2.64 million in the year following its Korean launch, ...

Workforce shortages accounted for 77 percent of department-specific emergency room care restriction notices in Korea in the first half of this year, with pediatrics reporting the most cases, governmen ...

Severance Cardiovascular Hospital has performed 10,000 atrial fibrillation ablation procedures, becoming the first single ...

Korean researchers have identified a previously unknown mechanism that amplifies lymphatic vessel signaling, offering a potential new target for research into lymphedema and cancer metastasis.Lymphati ...

Samsung Bioepis said Friday that it has partnered with Teva Pharmaceutical Industries to develop and commercialize two ...

Huons will unveil preclinical data on investigational gastrointestinal and oral obesity drug candidates at two global ...

The Korea Health Industry Development Institute (KHIDI) has opened a K-beauty flagship hub in Paris, aiming to help small- ...